M&A Deal Summary

Derma Sciences Acquires BioD

On July 28, 2016, Derma Sciences acquired life science company BioD for 21M USD

Acquisition Highlights
  • This is Derma Sciences’ 2nd transaction in the Life Science sector.
  • This is Derma Sciences’ largest (disclosed) transaction.
  • This is Derma Sciences’ 4th transaction in the United States.
  • This is Derma Sciences’ 1st transaction in Tennessee.

M&A Deal Summary
Date 2016-07-28
Target BioD
Sector Life Science
Buyer(s) Derma Sciences
Deal Type Add-on Acquisition
Deal Value 21M USD
Advisor(s) Canaccord Genuity Corp. (Financial)
Baker, Donelson, Bearman, Caldwell & Berkowitz (Legal)

Target

BioD

Cordova, Tennessee, United States
website
BioD LLC is a developer of allografts from placental tissue to aid in wound healing. It has more than 25 U.S. patents issued and pending covering its novel products, proprietary processing techniques and the clinical use of its products. Its products are used in a broad range of clinical applications including the treatment of complex chronic wounds, acute wounds and localized areas of injury on inflammation.

Search 192,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Derma Sciences

Princeton, New Jersey, United States

website

Category Company
Founded 1984
Sector Medical Products
Employees299
Revenue 84M USD (2015)
DESCRIPTION

Derma Sciences, Inc. is an integrated manufacturer, marketer and supplier of dermatological related product lines, including: wound care, wound closure and specialty securement devices, and skin care.

DEAL STATS #
Overall 4 of 5
Sector (Life Science) 2 of 2
Type (Add-on Acquisition) 3 of 3
State (Tennessee) 1 of 1
Country (United States) 4 of 4
Year (2016) 1 of 1
Size (of disclosed) 1 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-07-13 Quick-Med Technologies - NIMBUS Technology

Gainesville, Florida, United States

Quick-Med Technologies, Inc. - NIMBUS Technology includes exclusive global license to intellectual property related to the novel NIMBUS® antimicrobial technology, which is available in BIOGUARD® dressings.

Buy $1M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-01-11 Comvita - MEDIHONEY

New Zealand

Comvita Ltd. - MEDIHONEY is an advanced wound care dressing that is supported by over 160 pieces of evidence demonstrating its clinical ability to promote the removal of necrotic tissue and advance a wound toward healing.

Buy $13M
Mergr

Product

Company

Legal